Viewing Study NCT07110194


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2025-12-25 @ 11:57 PM
Study NCT ID: NCT07110194
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-07
First Post: 2025-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies
Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module